Endocrine 2 (Type 2 Diabetes | Cardio Risk ) Flashcards

1
Q

What is Type 2 Diabetes

A

Insulin Resistance
Hyperinsulinemia
Hyperglycemia

  • Later stages beta-cell destruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Type 1 vs Type 2 Diabetes

A

Type 1 can be treated with insulin therapy

Type 2 can only be treated with insulin therapy at later stages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Methods to lower glucose in Type 2 Diabetes

A

Overcome Insulin Resistance

Insulin Independent Methods of Glucose-Lowering

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Overcome Insulin Resistance
- Methods?

A
  • Insulin Secretagogues
  • Thiazolidinedione
  • Metformin?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Insulin Independent Methods of Glucose-Lowering
- Methods?

A

Decrease Hepatic Glucose Production
- Metformin

Prevent Dietary Glucose Absorption
- Alpha-Glucosidase Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Secretagogues
- Examples

A

1st Generation Sulfonylureas
- Tolbutamide, Chlorpropamide, Acetohexamide

2nd Generation Sulfonylureas
- Glyburide, Glipizide, Glimepiride

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Secretagogues
- 1st vs 2nd Generation

A

2nd Generation Sulfonylureas:
- More potent
- Shorter half life
- Fewer side effects

Less dose needed to get insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Secretagogues
- MOA

A
  1. Sulfonylurea binds the sulfonylurea receptor/subunit of the K(ATP) channel
  2. Inhibits K(ATP) channel
  3. Prevents K+ efflux causing depolarization
  4. Activates Ca2+ channels causing Ca2+ influx
  5. Exocytosis of insulin from insulin granules

Result: Increased Insulin Secretion to overcome Insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Secretagogues
- Adverse Effects

A
  • Hypoglycemia
  • Weight Gain
  • Cardiovascular Complications (KATP channels are important in preventing ischemic events)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Non-Sulfonylurea Secretagogues
- Example

A
  • Repaglinide
  • Nateglinide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Non-Sulfonylurea Secretagogues
- MOA

A
  1. Binds to a different site on K(ATP) Channel
  2. Inhibits K(ATP) channel
  3. Prevents K+ efflux causing depolarization
  4. Activates Ca2+ channels causing Ca2+ influx
  5. Exocytosis of insulin from insulin granules

More selective for beta cell K(ATP) channels than cardiac cell K(ATP) channels

Rapid onset and Short duration
- Lower risk of hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Alpha-Glucosidase Inhibitors
- Examples

A
  • Acarbose
  • Miglitol
  • Voglibose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Alpha-Glucosidase Inhibitors
- MOA

A
  1. Competitive inhibitor of intestinal alpha-glucosidase enzyme.
  2. Preventing the breakdown disaccharides
  3. Delays/Decreases absorption of monosaccharides
  4. Reduces postprandial glucose rise

Result: Preventing dietary glucose absorption, thus, lowering glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alpha-Glucosidase Inhibitors
- Adverse Effects

A
  • Least effective oral antidiabetic drug
  • Does not influence insulin = No Hypoglycemia
  • Unbroken sugars cause issues GI issues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Thiazolidinediones
- Examples

A

Rosiglitazone, Pioglitazone, Troglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Thiazolidinediones
- MOA

A

Insulin Sensitizer
1. Peroxisome Proliferator Activated Receptor Gamma Agonist (PPAR Gamma)
- Nuclear Receptor in Adipose Tissue
2. Manages gene expression to promote uptake and storage of fatty acids into adipose tissue
3. Improves muscle insulin sensitivity as excess fat is not stored in organs

Takes 6-12 Weeks to reach full effect

17
Q

Thiazolidinediones
- Adverse Effects

A
  • Weight Gain
  • Cardiovascular (Rosiglitazone does not actually increase risk of heart attacks, however, its reputation is already ruined)
  • Cancer
18
Q

Biguanides
- Examples

A

Metformin

19
Q

Biguanides
- MOA

A

First Line Therapy
- Increases AMPK, an important regulator in energy metabolism
- Inhibits Glucagon Signaling in Liver
- Decreases hepatic gluconeogenesis
- Promotes glucose uptake skeletal muscle

20
Q

Biguanides
- AMPK

A
  1. Metformin increases AMPK
  2. AMPK inhibits Acetyl CoA Carboxylase (ACC)
  3. Increased fatty acid oxidation (Breakdown of Fat)
  4. Decreased Hepatic Glucose Production
    (Less Fatty Liver = Less Glucose Production)

Result: Lower Blood Glucose Levels

21
Q

Biguanides
- Glucagon

A
  1. Metformin inhibits Glucagon signaling
  2. Prevents Glucagon from activating Hepatic Gluconeogenesis
  3. Decreased Hepatic Glucose Production

Result: Lower Blood Glucose Levels

22
Q

Biguanides
- Adverse Effects

A
  • Independent from Insulin = No Hypoglycemia
  • GI Symptoms
  • Lactic Acidosis (Phenformin)
    –> Build up of lactic acid does acidifies the blood